Tirzepatide is a dual GLP-1 and GIP receptor agonist designed to support appetite regulation and metabolic function through complementary hormonal signaling. By activating both GLP-1 and GIP pathways, tirzepatide enhances satiety, improves glucose regulation, and supports reduced caloric intake within a structured, clinician-supervised program.
This therapy supports sustainable weight management by engaging multiple metabolic pathways involved in hunger and insulin response.
This purchase includes clinical evaluation, prescription, tirzepatide medication, supplies, and direct shipping for a 30-day program.
If the reviewing clinician determines you are not eligible, you will receive a refund minus a $30 exam processing fee.
Tirzepatide is a dual GLP-1 and GIP receptor agonist designed to support appetite regulation and metabolic function through complementary hormonal signaling. By activating both GLP-1 and GIP pathways, tirzepatide enhances satiety, improves glucose regulation, and supports reduced caloric intake within a structured, clinician-supervised program.
This therapy supports sustainable weight management by engaging multiple metabolic pathways involved in hunger and insulin response.
This purchase includes clinical evaluation, prescription, tirzepatide medication, supplies, and direct shipping for a 30-day program.
If the reviewing clinician determines you are not eligible, you will receive a refund minus a $30 exam processing fee.